Tiny Biotech Rallybio Stock Surges As $500 Million-Backed Merger Fuels Investor Optimism
Rallybio Shares Successful Early-Stage Results for Rare Disease Drug; New Trial Set for Late 2026
Why Is Microcap Rallybio Stock Trading Higher On Tuesday?
Rallybio Stock Plunges After Program For Pediatric Bleeding Disorder Disappoints